Your browser doesn't support javascript.
loading
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial.
Lübbert, Michael; Wijermans, Pierre W; Kicinski, Michal; Chantepie, Sylvain; Van der Velden, Walter J F M; Noppeney, Richard; Griskevicius, Laimonas; Neubauer, Andreas; Crysandt, Martina; Vrhovac, Radovan; Luppi, Mario; Fuhrmann, Stephan; Audisio, Ernesta; Candoni, Anna; Legrand, Olivier; Foà, Robin; Gaidano, Gianluca; van Lammeren-Venema, Danielle; Posthuma, Eduardus F M; Hoogendoorn, Mels; Giraut, Anne; Stevens-Kroef, Marian; Jansen, Joop H; de Graaf, Aniek O; Efficace, Fabio; Ammatuna, Emanuele; Vilque, Jean-Pierre; Wäsch, Ralph; Becker, Heiko; Blijlevens, Nicole; Dührsen, Ulrich; Baron, Frédéric; Suciu, Stefan; Amadori, Sergio; Venditti, Adriano; Huls, Gerwin.
Affiliation
  • Lübbert M; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany. Electronic address: michael.luebbert@uniklinik-freiburg.de.
  • Wijermans PW; Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands.
  • Kicinski M; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Chantepie S; Department of Hematology, Centre Hospitalo-Universitaire de Caen, Caen, France.
  • Van der Velden WJFM; Department of Hematology, Radboud University, Nijmegen, Netherlands.
  • Noppeney R; Klinik für Hämatologie und Stammzelltransplantation, University Hospital Essen, Essen, Germany.
  • Griskevicius L; Department of Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius University, Vilnius, Lithuania.
  • Neubauer A; Department of Internal Medicine, Hematology, Oncology and Immunology, Philipps University Marburg and University Hospital Gießen and Marburg, Campus Marburg, Marburg, Germany.
  • Crysandt M; Department of Hematology, Oncology, Hemostasiology and Stem Cell Transplantation, Medical Clinic IV, University Hospital RWTH Aachen, Aachen, Germany.
  • Vrhovac R; Department of Haematology, University Hospital Centre Zagreb, Zagreb, Croatia.
  • Luppi M; Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, University of Modena and Reggio Emilia, Azienda Ospedaliera Universitaria, Modena, Italy.
  • Fuhrmann S; Department of Hematology and Oncology, Helios Hospital Berlin-Buch, Kiel, Germany.
  • Audisio E; Department of Haematology, Azienda Ospedaliera Città della Salute e della Scienza di Torino-Ospedale Molinette, Torino, Italy.
  • Candoni A; Clinica Ematologica Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy.
  • Legrand O; Service d'Hématologie Clinique et de Thérapie cellulaire, Hôpital Saint Antoine, APHP, Paris, France.
  • Foà R; Ematologia, Dipartimento di Medicina Traslazionale e di Precisione, Sapienza Università di Roma, Rome, Italy.
  • Gaidano G; Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale and Azienda Ospedaliero-Universitaria Maggiore della Carità, Novara, Italy.
  • van Lammeren-Venema D; Department of Hematology, Haga Teaching Hospital, The Hague, Netherlands.
  • Posthuma EFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, Netherlands.
  • Hoogendoorn M; Department of Hematology, Medical Center Leeuwarden, Leeuwarden, Netherlands.
  • Giraut A; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Stevens-Kroef M; Department of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
  • Jansen JH; Laboratory Hematology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • de Graaf AO; Laboratory Hematology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
  • Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy.
  • Ammatuna E; University Medical Center Groningen, Groningen, Netherlands.
  • Vilque JP; Department of Hematology, Centre Hospitalo-Universitaire de Caen, Caen, France.
  • Wäsch R; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
  • Becker H; Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
  • Blijlevens N; Department of Hematology, Radboud University, Nijmegen, Netherlands.
  • Dührsen U; Klinik für Hämatologie und Stammzelltransplantation, University Hospital Essen, Essen, Germany.
  • Baron F; GIGA-I3 and Centre Hospitalier Universitaire, University of Liège, Liège, Belgium.
  • Suciu S; The European Organisation for Research and Treatment of Cancer (EORTC) Headquarters, Brussels, Belgium.
  • Amadori S; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Venditti A; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
  • Huls G; University Medical Center Groningen, Groningen, Netherlands. Electronic address: g.huls@umcg.nl.
Lancet Haematol ; 10(11): e879-e889, 2023 Nov.
Article in En | MEDLINE | ID: mdl-37914482
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Aged / Humans / Middle aged Language: En Journal: Lancet Haematol Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute Limits: Aged / Humans / Middle aged Language: En Journal: Lancet Haematol Year: 2023 Document type: Article